Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis

Fig. 2

Comprehensive analysis of risk stratification, pathway enrichment, immune signatures, and drug sensitivity in gastric cancer. (A) risk score assessment of tumor-related pathway scores. (B) Correlation between different risk groups and the expression of immune-related genes. (C) Tumor immune dysfunction and exclusion (TIDE) scores in different risk groups. (D) prediction of drug sensitivity of prognostic-related genes

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us